Open AccessInitial Kinetic Characterization of Sterile Alpha and Toll/Interleukin Receptor Motif-Containing Protein 1
Author(s) -
Heather S. Loring,
Janneke D Icso,
Venkatesh V. Nemmara,
Paul R. Thompson
Publication year - 2020
Publication title -
biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.43
H-Index - 253
eISSN - 1520-4995
pISSN - 0006-2960
DOI - 10.1021/acs.biochem.9b01078
Subject(s) - nad+ kinase , neurodegeneration , enzyme kinetics , nicotinamide , gene knockdown , nicotinamide adenine dinucleotide , chemistry , receptor , biology , microbiology and biotechnology , enzyme , gene , biochemistry , active site , medicine , disease , pathology
Sterile alpha and toll/interleukin receptor (TIR) motif-containing protein 1 (SARM1) plays a pivotal role in triggering the neurodegenerative processes that underlie peripheral neuropathies, traumatic brain injury, and neurodegenerative diseases. Importantly, SARM1 knockdown or knockout prevents degeneration, thereby demonstrating that SARM1 is a promising therapeutic target. Recently, SARM1 was shown to promote neurodegeneration via its ability to hydrolyze NAD + , forming nicotinamide and ADP ribose (ADPR). Herein, we describe the initial kinetic characterization of full-length SARM1, as well as the truncated constructs corresponding to the SAM 1-2 TIR and TIR domains, highlighting the distinct challenges that have complicated efforts to characterize this enzyme. Moreover, we show that bacterially expressed full-length SARM1 ( k cat / K M = 6000 ± 2000 M -1 s -1 ) is at least as active as the TIR domain alone ( k cat / K M = 1500 ± 300 M -1 s -1 ). Finally, we show that the SARM1 hydrolyzes NAD + via an ordered uni-bi reaction in which nicotinamide is released prior to ADPR.